- Previous Close
0.860 - Open
0.860 - Bid 0.830 x --
- Ask 0.860 x --
- Day's Range
0.830 - 0.860 - 52 Week Range
0.450 - 1.230 - Volume
17,000 - Avg. Volume
119,483 - Market Cap (intraday)
440.821M - Beta (5Y Monthly) 1.51
- PE Ratio (TTM)
28.67 - EPS (TTM)
0.030 - Earnings Date Mar 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date May 19, 2015
- 1y Target Est
--
Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It also offers clean utility and bioprocess equipment, clean room, automation control and monitor system; bioprocess equipment consumables, and laboratory solutions. In addition, the company provides pharmaceutical process contamination control; packaging and aseptic containment; biosafety lab animal equipment, and consumables, as well as offers powder and solid equipment; freeze-dryer, sterile filling and visual inspection equipment. Further, it offers project management and process engineering; engineering design and consulting services; operation and maintenance of facility management systems. Additionally, the company provides lifecycle digital solutions and professional consulting services. Austar Lifesciences Limited was founded in 1991 and is headquartered in Shanghai, China.
www.austar.com.hkRecent News: 6118.HK
View MorePerformance Overview: 6118.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6118.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6118.HK
View MoreValuation Measures
Market Cap
440.82M
Enterprise Value
691.42M
Trailing P/E
26.78
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.27
Price/Book (mrq)
0.52
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
16.92
Financial Highlights
Profitability and Income Statement
Profit Margin
1.07%
Return on Assets (ttm)
1.02%
Return on Equity (ttm)
1.73%
Revenue (ttm)
1.5B
Net Income Avi to Common (ttm)
16.08M
Diluted EPS (ttm)
0.030
Balance Sheet and Cash Flow
Total Cash (mrq)
167.8M
Total Debt/Equity (mrq)
50.66%
Levered Free Cash Flow (ttm)
78.9M